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Abstract
Background: Almost 50% of Americans have elevated low-density lipoprotein cholesterol (LDL-C). The behaviors required
to lower LDL-C levels may be difficult to adhere to if they are inconsistent with spouses' health practices, and, alternatively, may
be enhanced by enlisting support from the spouse. This trial extends previous trials by requiring spouse enrollment, teaching
spouses how to provide emotional and instrumental support, allowing patients to decide which component of the intervention
they would like to receive, and having patients determine their own goals and action plans.
Methods: Veteran outpatients with above-goal LDL-C (N = 250) and their spouses are randomized, as a couple, to receive
printed education materials only or the materials plus an 11-month, nurse-delivered, telephone-based intervention. The
intervention contains four modules: medication adherence, diet, exercise, and patient-physician communication. Patients decide
which modules they complete and in which order; modules may be repeated or omitted. Telephone calls are to patients and
spouses separately and occur monthly. During each patient telephone call, patients' progress is reviewed, and patients create
goals and action plans for the upcoming month. During spouse telephone calls, which occur within one week of patient calls,
spouses are informed of patients' goals and action plans and devise strategies to increase emotional and instrumental support.
The primary outcome is patients' LDL-C, measured at baseline, 6 months, and 11 months. Linear mixed models will be used to
test the primary hypothesis that an 11-month, telephone-based patient-spouse intervention will result in a greater reduction in
LDL-C as compared to printed education materials. Various process measures, including social support, self-efficacy, medication
adherence, dietary behavior, and exercise, are also assessed to explain any change, or lack thereof, in LDL-C.
Discussion: Given the social context in which self-management occurs, interventions that teach spouses to provide
instrumental and emotional support may help patients initiate and adhere to behaviors that lower their LDL-C levels. Moreover,
allowing patients to retain autonomy by deciding which behaviors they would like to change and how may improve adherence
and clinical outcomes.
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Trials 2009, 10:10 http://www.trialsjournal.com/content/10/1/10Coronary heart disease (CHD) is the leading cause of
death in the United States, resulting in more than 500,000
deaths and an additional 500,000 nonfatal heart attacks
annually.[1,2] One major modifiable risk factor for CHD
is elevated low-density lipoprotein cholesterol (LDL-C).
Every 1% reduction in LDL-C is accompanied by a 1%
reduction in individuals' short-term risk of a major coro-
nary event.[2] Consequently, current guidelines designate
LDL-C as the primary target of lipid-lowering therapy.[2]
Despite the proven efficacy of lifestyle modifications and
lipid-lowering medications, almost half of American
adults have borderline high or high LDL-C, defined as 130
mg/dL or above.[2] Therefore, novel interventions are
needed to lower LDL-C levels.
Patient interventions have proven effective for increasing
adherence to behaviors that would lower LDL-C lev-
els.[3,4] However, changes are typically short lived, with
less healthy behaviors returning after brief periods of
time. One reason for nonadherence is that recommended
lifestyle behaviors may be inconsistent with those of one's
social network members.[4,5] Moreover, patients may
have difficulty adhering to dietary changes when they are
not involved in cooking meals or grocery shopping.[6]
What is needed, then, are interventions that can enhance
the social support provided by spouses/significant others
in order to help patients adhere better to treatment recom-
mendations.
Several trials have shown that spouses can help patients
lower their cholesterol.[7,8] However, these studies have
some limitations. First, they have targeted a young popu-
lation.[9] or women. [10,11] Thus, these studies do not
generalize to the VA setting, which consists of primarily
older males for whom the female spouse is the primary
meal planner. Second, these studies have evaluated rela-
tively short-term interventions (i.e., less than 6
months).[9,11] Third, previous studies have simply
encouraged emotional support, rather than teaching
spouses how to provide better emotional and instrumental
support. [10,12] This is important because spouses may
do things to decrease treatment adherence (e.g., nagging).
Fourth, previous studies have not allowed patients to cre-
ate their own goals and action plans (i.e., steps for achiev-
ing those goals). This is important because people who are
not ready to make a behavior change – especially one
imposed on them – are unlikely to be adherent.[13]
Finally, these studies have targeted only one component
of the treatment regimen at a time – either lifestyle
changes or medication adherence.[9,12]
Our proposed intervention, the CouPLES trial, extends
interventions tested in previous studies in several ways.
We will: (1) target elderly male veterans, a group at
increased risk for dyslipidemia and associated morbidity;
(2) assess both short-term (6 months) and long-term (11
months) effects of the intervention; (3) employ a multi-
component intervention that includes modules for medi-
cation, diet, exercise, and patient-physician communica-
tion – all important components of treatment for
dyslipidemia; (4) have patients create goals and action
plans for whichever behavior they would like to change;
and (5) teach spouses strategies to provide support that
can enhance patients' adherence to healthy behaviors. In
this paper, we describe the study design, recruitment strat-
egy, and analytical techniques of a clinical trial to test this
state-of-the-art CouPLES intervention.
Methods
Setting and overall study design
This randomized controlled trial is being conducted at the
Durham Veterans Affairs Medical Center (VAMC) and was
approved by the Durham VAMC Institutional Review
Board. Written informed consent was obtained from the
patient for publication of this case report and accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal. Patients are
recruited from the primary care clinics, which are staffed
by Internal Medicine faculty physicians, house staff physi-
cians, physician assistants, and nurse practitioners. Eligi-
ble patients and their spouses are randomized, as a
couple, to receive printed educational materials only
(control arm) or printed educational materials plus the
CouPLES intervention (intervention arm). During the
study, all patients continue to receive usual care from their
physician. The intervention is delivered over 11 months
via a series of monthly telephone calls to both members
of the couple. Patient outcomes are assessed at 6 and 11
months.
Patient population and recruitment
Our study population consists of married veterans with
above-goal LDL-C. According to current guidelines, a
patient's LDL-C goal depends on the number of major risk
factors and the estimated 10-year risk for CHD according
to the Framingham risk score.[2] The three risk categories
and corresponding LDL-C goals are shown in Table 1.
We identify potential participants via a three-step process
(Figure 1). In Step 1, we use VA administrative databases
to identify married patients who have had a primary care
visit and a lipid profile with LDL-C >100 mg/dL in the pre-
vious 12 months. We chose a cutoff of 100 mg/dL because
that is the lowest possible guideline-recommended LDL-C
goal. We also use the databases to exclude patients who
meet any of the exclusion criteria listed in Step 1 of Figure
1.
In Step 2, patients who have an upcoming clinic appoint-
ment receive a recruitment letter, followed by a screeningPage 2 of 9
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screening telephone call, patients who meet any of the
exclusion criteria listed Step 2 of Figure 1 are excluded.
Patients passing Step 2 are scheduled for an in-person
screening visit with a research assistant (RA). Spouses are
also required to attend; in most cases, spouses have been
able to come at the same time as patients. This may not be
true in a younger population that is more likely to be
employed and caring for young children.
In Step 3, self-reported data and laboratory results
obtained during the screening visit, combined with medi-
cal record data, are used to count patients' risk factors and
calculate their Framingham risk scores (see Figure 1, Step
3). This information is used to determine patients' risk
categories, as defined in Table 1, and their individual LDL-
C goals based on the risk categories. Patients with above-
goal LDL-C are eligible for enrollment. Eligible couples
are randomized, as a pair, to the intervention or control
arm. The randomization is stratified on patient race
(White and non-White) and risk category (collapsed from
three categories to two – high and medium/low – due to
the low prevalence of the low-risk category). This will
allow us to test for differential effects of the intervention
on different race and risk groups, which will inform future
interventions.
The screening visit also serves as the baseline visit for eli-
gible patients. At this visit, patients and spouses provide
written informed consent, complete baseline measures,
and receive printed educational materials. After the visit,
the research nurse who delivers the CouPLES intervention
places a telephone call to inform patients of their labora-
tory results, eligibility, and when eligible, randomization
assignment. During this telephone call as well as the inter-
vention telephone calls preceding follow-up assessments,
the nurse instructs couples not to reveal their study assign-
ment to the RA so that the RA will be blinded for outcome
assessments. Each couple receives $40 for each of the
three visits.
CouPLES intervention
Overview
The CouPLES intervention takes place over 11 months
(Figure 2). A research nurse delivers the CouPLES inter-
Table 1: Risk categories and LDL-C (mg/dL) goal
Risk Category LDL-C Goal
High: CHD and risk equivalents* <100
Medium: No CHD, ≥ 2 risk factors** <130
Low: No CHD, 0–1 risk factor <160
LDL-C: low-density lipoprotein cholesterol. CHD: coronary heart 
disease.
*Risk equivalents: diabetes, clinical forms of atherosclerotic disease, 
and multiple risk factors that confer a 10-year risk for CHD > 20% 
according to the Framingham risk score. **Risk factors: hypertension 
(blood pressure ≥ 140/90 mmHg or on antihypertensive medication), 
cigarette smoking, high-density lipoprotein cholesterol < 40 mg/dL, 
age (men ≥ 45 years, women ≥ 55 years), and family history of 
premature coronary heart disease (present in male first degree 
relative < 55 years or female first degree relative < 65 years).
Steps in identifying potentially eligible patientsFigure 1
Steps in identifying potentially eligible patients.
Step 1: Administrative 
data review
Inclusion criteria
•Married
•Primary care visit 
during past year
•LDL-C>100 mg/dL in 
past year
Exclusion criteria
•No specified primary 
care provider
•No telephone 
number
•Hospitalization in 
past 3 months
•Psychosis or 
dementia
•Resident of long-
term care at the VA
Step 2: Screening phone 
call
Exclusion criteria
•Patient
•Unmarried
•Unwilling to have 
lipid panel
•Enrolled in another 
study focusing on 
lifestyle changes
•Spouse: unwilling to 
participate
•Patient or spouse:
•Cognitively impaired
•Unable to 
communicate via 
telephone
•Living in nursing 
home or receiving 
home health care
•Health problem that 
precludes 
participation
Step 3: Screening visit
•Information is used to 
count risk factors and 
calculate Framingham 
score to determine LDL-
C goal
•Non-fasting lipid 
panel: HDL-C, total 
cholesterol
•Self-report: Smoking 
status, diagnosis of 
hypertension, use of 
antihypertensive 
medication, and 
family history of CHD
•Medical record: Risk 
equivalents and blood 
pressure values
•Exclusion criterion: LDL-
C obtained at visit is at or 
below goalPage 3 of 9
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required (e.g., for issues with medications or comorbidi-
ties). Prior to enrollment, the nurse received didactic
training from a clinical psychologist (S.K.) on the basic
principles of motivational interviewing, including asking
open-ended questions, learning how to use reflective lis-
tening, and learning to identify and elicit change talk from
a patient. The nurse also learned how and when to rein-
force patients and to express optimism about their ability
to change. The nurse received feedback on several practice
intervention calls to both patients and spouses from C.V.
and S.K. During the trial, 5% of calls are recorded and
reviewed to assure intervention fidelity, and feedback is
provided as necessary.
The research nurse conducts all intervention telephone
calls with patients and spouses separately. During the
month 1 telephone call, patients and spouses receive an
educational module. During the month 2 telephone call,
patients choose one of four topical modules and create
corresponding goals and action plans. During subsequent
monthly telephone calls, which occur every month except
months 6 and 11 when outcomes are assessed, patients'
progress is reviewed, and patients revise or create new
goals and action plans for the same or a different module.
During all spouse telephone calls, spouses are informed of
patients' goals and action plans and are provided with
strategies to provide better emotional and instrumental
support to help increase patient adherence. For example,
spouses may exercise with patients or prepare their lunch
so that they do not have to eat at a restaurant.
Module content
At month 1, the nurse delivers an educational module that
reviews the importance of blood cholesterol to health,
treatments for dyslipidemia, and principles of self-man-
agement. In the spouse educational call, the nurse also
reviews behavioral principles for providing instrumental
and emotional social support. Although this information
is provided in the printed materials distributed at base-
line, the nurse reviews it to ensure that all intervention
patients will receive the information, regardless of levels
of health literacy, and so that the nurse can answer any
questions or clarify the information. Below, we describe
the content of each of the four topical modules and proc-
esses for delivery.
Diet
The educational materials include a handout on portion
sizes and the National Heart, Lung, and Blood Institute's
cookbook Keep the Beat: Heart-Healthy Recipes. We
designed the diet module to be applicable regardless of
whether the patient or spouse is the primary meal pre-
parer in the home, and we provide different suggestions
for people who do and do not cook. The nurse asks
spouses if they plan to make the same dietary changes as
the patients and provides appropriate suggestions.
Exercise
Patients receive a handout emphasizing the importance of
exercise to health and suggesting ways to start an exercise
program, stay motivated, deal with pain, and prevent
overexertion. As in the diet module, the nurse asks
spouses if they plan to exercise with patients and provides
appropriate suggestions.
Medication adherence
This module will only be applicable to patients who are
on lipid-lowering medications (which is not an inclusion
criterion) and who need assistance to increase medication
adherence. We provide information sheets on lipid-lower-
ing medications that include dosages, dosing instructions,
the most common side effects, and important warnings,
all written at an eighth grade reading level. Suggestions to
spouses correspond to patients' goals and may include
ordering refills, encouraging patients to contact their
pharmacist or physician about side effects, and helping
patients prepare pill boxes.
Patient-physician communication
The written materials suggest ways patients can improve
the quantity and quality of communication with their
providers. The nurse provides practical suggestions for
Intervention flowchartFigur  2
Intervention flowchart.Page 4 of 9
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ages role-playing with spouses to increase patients' self-
efficacy. The nurse also helps patients problem-solve and
set goals that are reasonable to accomplish at their next
clinic visit using methods such as role-playing.
Module delivery
During the initial patient telephone call, patients choose
one of the four topics. The nurse asks open-ended ques-
tions about what they have tried in the past, what has
worked, and what has not worked. The nurse also uses
reflective listening to help patients establish possible
goals related to the topic chosen. The nurse asks patients
to rank each possible goal in order of importance to deter-
mine which goals will be pursued in the upcoming
month. Next, the nurse uses open-ended questions to
elicit from patients how they will attempt to make the
behavior changes necessary to reach that month's goals
and how to integrate the spouse in the plan; these specific
behaviors are designated as action plans. For each action
plan, patients are asked to rate their self-efficacy on a 1–
10 scale (1 = not at all confident, 10 = very confident).
Patients reporting < 7 are asked to revise their action plans
and/or goals until ratings ≥ 7 are provided, as patients will
be more likely to accomplish their goals.[14] Patients are
asked to record that month's goals and action plans on
provided goal sheets, which they can refer to anytime.
The follow-up patient calls take place 3–5 weeks after the
initial calls (i.e., there is a 2-week window during which
calls must occur, otherwise the call is skipped). During
these calls, patients are asked whether they met their
goals. Patients who met their goals are reinforced and
encouraged to create additional goals and action plans.
Patients who did not meet their goals are encouraged to
modify their original goals and action plans or create new
one(s).
All spouse calls occur within one week of the patient calls.
During these calls, spouses are informed of whether
patients indicated that they met their goals and about
patients' new or revised goals and action plans. Spouses
are encouraged to think of ways to help patients achieve
their new or revised goals and, when necessary, are pro-
vided with suggestions.
This intervention takes into account patients' motivation
to change specific behaviors by allowing them to deter-
mine which modules they receive and the order in which
they receive them. This way, patients address the areas
about which they are most motivated to make behavioral
changes. Some patients may not wish to complete one or
more modules. Because this is a patient-centered interven-
tion, the protocol is flexible so that modules can be
repeated or omitted.
Information technology for intervention delivery
Two customized database applications were created: one
for the delivery of the CouPLES intervention, and one for
the tracking of all related data. Once couples are rand-
omized to the intervention, relevant information is auto-
matically transferred from the study tracking database to
the intervention application database to facilitate inter-
vention delivery. This information includes participants'
names, contact information, demographic data, and con-
tact information for patients' VA primary care provider.
Once couples' information enters the intervention appli-
cation database, the nurse can track the date on which the
next telephone intervention call is due to both patients
and spouses, as well as dates of previous intervention tel-
ephone calls. Several other important features of the
application facilitate tracking of telephone calls. First, a
calendar notes the patient-specified best days and times to
be reached. This information is obtained by the nurse dur-
ing the educational telephone call and allows calls to be
made when the participant is most likely to be available.
The application provides lists of all patients and spouses
due for telephone calls and notes those who are currently
available. Second, the application allows the nurse to doc-
ument the number of missed calls, time periods when the
participant will be on vacation or otherwise unavailable,
and any other notes regarding availability. Third, the
application automatically records the duration of each tel-
ephone call. This information will be used in the eco-
nomic evaluation and will provide information regarding
the time required to implement this type of intervention
in a real-world clinical setting.
In addition to tracking telephone call schedules and data,
the application facilitates implementation of the interven-
tion. For each topical module, the application provides
scripts for the nurse to follow during each telephone call.
These scripts contain summary points, questions for
patients and spouses, and suggested behaviors that
patients and spouses could designate as action plans to
follow over the next month (Figures 3 and 4 display die-
tary suggestions from the patient and spouse diet mod-
ules; names are fictitious). Most importantly, the
application provides an interface for documenting and
tracking patients' goals and action plans (Figure 5 displays
goals and action plans for a fictitious patient). For a
selected topic, all goals and action plans are displayed,
and the software shows which goals are active, inactive, or
complete at the time of the telephone call. The application
also tracks patients' self-efficacy at the time action plans
are initiated, and whether the goal was initiated by the
participant or initially suggested by the nurse.Page 5 of 9
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Control variables are assessed at baseline. The primary,
secondary, and process measures are assessed at baseline,
6 months, and 11 months.
Control variables
Demographic variables (age, sex, race, education, finan-
cial stress, employment status) and clinical variables (cho-
lesterol medication use, frequency of cholesterol testing,
alcohol and tobacco use, antihypertensive medication
use, family history of CHD) are assessed at via self-report.
Health literacy is assessed with the Short Test of Func-
tional Health Literacy in Adults (S-TOFHLA).[15] Comor-
bidities are assessed with a self-report checklist.[16]
Primary outcome
LDL-C is measured directly using a non-fasting lipid pro-
file. We chose a non-fasting test because it reduces patient
burden and therefore may increase our enrollment rate.
The blood sample is analyzed with an LXi from Beckman
Coulter. The coefficient of variation for LDL-C ranges
from 3.3 % at 106 mg/dL to 4.1 % at 49 mg/dL.
Secondary outcomes
Dietary behavior is assessed with the Block Brief 2000
Food Frequency Questionnaire (FFQ).[17] Exercise is
assessed with the Community for Healthy Activities
Model Program for Seniors (CHAMPS) question-
naire.[18] Medication adherence is assessed with the Med-
Out index, which is calculated for each lipid-lowering
medication.[19]
Process measures
Several measures are collected to determine what is
responsible for LDL-C change. These include cholesterol
knowledge; self-efficacy and outcome expectancies for
each of the behaviors; spouse support for dietary
change.[20] and exercise;[21] satisfaction with the dyadic
relationship;[22] amount of patient-physician communi-
cation;[18] and intervention intensity (i.e., how many
phone calls were completed).
Sample size and statistical power
The primary hypothesis is:
(H1) An 11-month, telephone-based patient-spouse
intervention will result in a greater reduction in LDL-C as
compared to printed education materials.
In our sample size calculations, we assume no change for
patients who receive only printed education materials and
a 7% reduction in LDL-C (based on a 2-month pilot study
using the same intervention materials) for intervention
patients from baseline to 11 months. Based on a standard
deviation adjusted to account for correlation between
repeated measurements of the outcome, and using an
independent samples t-test with a 0.05 two-sided signifi-
cance level and 80% power, a sample size of 100 patients
per group is required to detect a 9.4 point (7%) difference
in change of LDL-C values between the intervention and
control groups. Because we assume an approximate drop-
out rate of 20%, we will recruit approximately 125 cou-
ples per arm.
Patient telephone script from diet applicationFigure 3
Patient telephone script from diet application.
Spouse telephone script from diet applicationFig r  4
Spouse telephone script from diet application.Page 6 of 9
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The unit of analysis is the patient. Because LDL-C, a con-
tinuous variable, is assessed at baseline, 6 months, and 11
months, we will use a linear mixed-effects model
(LMM).[23] Fixed effects in the model will include inter-
vention group, time, and the interaction between these
two variables. This will enable us to determine the effects
of the intervention at both 6 and 11 months. Patient-level
random effects will be included in the model to account
for correlations between patients' repeated measures over
time. Primary analyses will be conducted as intent-to-
treat, and sensitivity analyses will examine the implica-
tions of the intent-to-treat assumption.
Secondary analyses
The secondary hypotheses are that patients who receive
the intervention will have significantly greater medication
adherence and exercise, and consume fewer calories, com-
pared to patients who only receive printed education
materials. Because these outcomes are continuous and are
assessed at three time points for each patient, we will use
LMMs. We are also interested in changes in self-efficacy,
spousal support, and patient-physician communication.
We will examine whether changes in these process meas-
ures are responsible for changes in LDL-C at both 6 and 11
months using currently accepted methods.[24,25]
Economic evaluation
The period of analysis will be the 11-month intervention
period. The base-case cost analysis will be conducted from
the VA's perspective. We will estimate the average annual
cost of the intervention per patient as well as the cost of
resource utilization, focusing on primary care visits and
cholesterol medications. Additionally, if the intervention
is more effective than printed education materials, we will
assess the incremental cost-effectiveness of the interven-
tion. For the cost-effectiveness analysis, we will use per-
cent reduction in LDL-C as the effectiveness measure.
Discussion
Recommended therapies for LDL-C reduction are only
effective if patients are adherent.[26,27] Unfortunately,
patient adherence to CHD prevention treatment is sub-
optimal, resulting in LDL-C levels above guideline-recom-
mended goals. Increasing the support provided to patients
is likely to improve their adherence to treatment recom-
mendations. In the CouPLES trial, we are assessing the
effectiveness of teaching patients and spouses strategies to
help increase patient adherence, which in turn should
lower LDL-C levels.
The CouPLES intervention is novel in a number of
respects. First, to our knowledge, this is the first patient-
spouse intervention that addresses all major components
of the lipid-lowering regimen. Second, rather than receiv-
ing topical modules in a prescribed order, patients can
decide which modules they would like to receive and how
often. They can choose one topic for the entire duration of
the study or choose any combination of topics. Third, we
use multiple modes to deliver the information, including
printed educational materials, telephone calls, and rein-
forcement by spouses. This is important because patients
typically receive information in one format (usually ver-
bally) in a single clinical encounter and are likely to mis-
understand or forget it. Fourth, the nurse teaches spouses
how to provide emotional and instrumental support
Patient goals from intervention delivery applicationFigure 5
Patient goals from intervention delivery application.Page 7 of 9
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Fifth, the nurse tailors suggestions according to whether
spouses intend or do not intend to make the same lifestyle
changes as patients. Finally, the intervention is delivered
by telephone, which has several advantages over face-to-
face strategies, including lower cost and wider
reach.[28,29] Telephone interventions allow a nurse to
follow a much larger panel than would be possible with
in-person interventions. For this reason, we will assess the
cost effectiveness of the intervention to help determine
the resources that would be necessary to implement it.
Conclusion
CHD is associated with significant healthcare costs, with
nearly $130 billion in direct and indirect costs in 2003.[1]
The expected increase in prevalence of CHD over the next
several decades will result in an increased burden for
many health care systems. Despite the known risk of ele-
vated LDL-C, patients are not adhering to the behaviors
necessary to achieve optimal LDL-C levels. Given that the
latest recommendations have even lower goals for LDL-
C,[30] more effective interventions are needed. If the Cou-
PLES intervention proves effective and low-cost, it could
help reduce future healthcare costs associated with the
long-term effects of elevated LDL-C levels.
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